Stuart George Michel 4
4 · QUESTCOR PHARMACEUTICALS INC · Filed Aug 26, 2008
Insider Transaction Report
Form 4
Stuart George Michel
CFO & Senior V.P. of Finance
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2008-08-25−90,000→ 310,000 totalExercise: $0.50Exp: 2015-09-26→ Common Stock (90,000 underlying) - Exercise/Conversion
Common Stock
2008-08-22$1.37/sh+52,499$71,924→ 146,455 total - Exercise/Conversion
Stock Options (Right to Buy)
2008-08-22−60,416→ 39,584 totalExercise: $0.98Exp: 2016-02-26→ Common Stock (60,416 underlying) - Sale
Common Stock
2008-08-25$5.05/sh−50,000$252,500→ 33,540 total - Exercise/Conversion
Stock Options (Right to Buy)
2008-08-22−52,499→ 87,501 totalExercise: $1.37Exp: 2017-02-08→ Common Stock (52,499 underlying) - Sale
Common Stock
2008-08-22$5.05/sh−112,915$570,221→ 33,540 total - Exercise/Conversion
Common Stock
2008-08-25$0.50/sh+90,000$45,000→ 123,540 total - Exercise/Conversion
Common Stock
2008-08-22$0.98/sh+60,416$59,208→ 93,956 total - Sale
Common Stock
2008-08-25$5.07/sh−40,000$202,800→ 83,540 total
Footnotes (3)
- [F1]The options were granted on February 27, 2006 and vest monthly over 48 months from the date of grant. The options had a twelve-month cliff, whereby no options vested until after the twelfth month.
- [F2]The options were granted on February 9, 2007 and vest monthly over 48 months from the date of grant. The options had a twelve-month cliff, whereby no options vested until after the twelfth month.
- [F3]The options were granted on September 27,2005 and vest monthly over 48 months from the date of grant. The options had a twelve-month cliff, whereby no options vested until after the twelfth month.